An ANGPTL8-AKT2-mTOR Axis Drives Adipose Senescence and Aging-Related Functional Decline
What this study shows
Identifies ANGPTL8 as an endocrine driver of adipose-tissue aging: circulating ANGPTL8 tracked with biological age and mortality risk in a large human cohort, and genetic deletion of Angptl8 in mice extended lifespan and reduced senescence markers. Mechanistically, ANGPTL8 binds AKT2 and drives the AKT-mTOR-S6K axis to promote adipocyte senescence; blocking that axis abolished the pro-senescent effect.
At a glance
| Evidence type | A Animal model Marked A because it is an animal intervention or observation study measuring an organismal outcome (model: Human cohort (correlation) + mouse (Angptl8-/- knockout, lifespan) + primary adipocyte/cell studies); the code names the system studied -- animal work can be rigorous and still not be human data. |
| Study type | 4 - Animal Study |
| Model system | Human cohort (correlation) + mouse (Angptl8-/- knockout, lifespan) + primary adipocyte/cell studies |
| Journal | Aging Cell |
| Year | 2026 |
| Peer reviewed | Yes |
| Record last updated | 2026-10-01 |
| Source | DOI 10.1111/acel.70671 · PMID 42605193 |
Extracted findings
These fields were extracted from the paper with AI assistance and have not been checked against the source. Read them as a pointer into the paper, not as curated claims; where they disagree with the curated summary above, the curated summary stands.
| Intervention | Angptl8 knockout (mouse lifespan); ANGPTL8 exposure with genetic or pharmacological AKT-mTOR-S6K inhibition in adipocytes; human cohort (observational) |
| Target | ANGPTL8-AKT2-mTOR-S6K axis |
| Model | Mouse; primary adipocytes; human cohort (correlative) |
| Effect | ANGPTL8 activates AKT-mTOR-S6K to promote adipocyte senescence; Angptl8 deletion extended mouse lifespan. |
In the Atlas
Related topics
More studies on this topic
- mTOR regulation and therapeutic rejuvenation of aging hematopoietic stem cells (2009)
- Therapeutic reversal of cellular senescence: A systematic review of senolytics, senomorphics and anti-ageing therapies in human clinical trials (2026)
- Rapamycin Attenuates Age-Related Changes in Marmoset Submandibular Gland: A Non-Human Primate Model of Human Oral Aging. (2026)
- Persistent mTORC1 signaling in cell senescence results from defects in amino acid and growth factor sensing (2017)
Was this page useful?
Thank you. Your answer was counted anonymously.